Almost every diet and exercise formula tested improved blood sugar in type 2 diabetes

Type 2 diabetes is managed day to day largely outside the clinic, through what people eat and how much they move. The practical question for patients, and especially for older patients, is whether lifestyle programmes genuinely shift the numbers that matter: blood glucose and blood lipids. There is also a quieter question underneath it, namely whether the benefit depends on picking one specific diet or training style, or whether many different approaches deliver. This review set out to evaluate diet and physical activity programmes, alone or combined, in people with type 2 diabetes including those aged 60 and over.

The authors conducted a systematic review of the PubMed and Medline database, with language restrictions, covering papers published between 2010 and 2016. They included 30 randomised controlled trials that tested physical activity interventions, dietary interventions or both in patients with type 2 diabetes mellitus, provided the trials included participants aged 60 years and over. The outcomes of interest were blood glucose values and lipid profile, the core biochemical markers of metabolic control in this condition.

The consistent finding across the included trials was improvement in both blood glucose levels and lipid profile. On the exercise side, this held across aerobic, resistance, flexibility and combined programmes. On the dietary side, benefits were seen with higher intakes of vegetables, grains, legumes, fruits and unsaturated fatty acids, consumption of low glycaemic index foods, and calorie restriction. The review also noted improvements linked to probiotic intake, vitamin D supplementation and educational sessions about diabetes. The authors conclude that physical activity and dietary programmes are fundamental to the treatment and metabolic control of type 2 diabetes.

This review confirms, rather than overturns, the standard position that lifestyle is central to managing type 2 diabetes, and it usefully shows the effect is not confined to one fashionable diet or one training modality. Its limits are worth naming: it searched a single database within a fixed window, applied language restrictions, and did not quantify how large the improvements were or compare approaches head to head. Which combination works best, for whom, and how durable the gains are remain open questions for trials designed to answer them.

For a reader with type 2 diabetes, or watching their blood sugar drift, the encouraging message is the breadth: in these trials, many reasonable versions of eating better and training regularly moved glucose and lipids in the right direction. That is a reason to pick an approach you can actually sustain rather than hunting for a single optimal protocol. It is informational, not a treatment plan; the trials tested structured programmes in people under medical care, and this review does not say how much improvement any individual should expect.